Writer Launches New LLMs For Healthcare And Finance Industries

Full Article
Writer Launches New LLMs For Healthcare And Finance Industries

Writer has unveiled two new large language models, Palmyra-Med and Palmyra-Fin, tailored for the healthcare and finance sectors. These models are designed to tackle specific challenges within their domains, utilizing extensive datasets to enhance accuracy and fluency. Palmyra-Med has achieved an impressive accuracy score of 85.9% on medical benchmarks, while Palmyra-Fin excels in financial data analysis.

The introduction of these models signifies a major advancement in domain-specific AI applications. Palmyra-Med aids healthcare professionals by providing reliable medical knowledge and personalized treatment plans, while Palmyra-Fin enhances financial decision-making through advanced data analysis. Both models are built on Writer's efficient architecture, making them accessible to a broader range of organizations.

• Palmyra-Med achieves 85.9% accuracy in medical benchmarks.

• Palmyra-Fin scores 73% on CFA Level III sample test.

Key AI Terms Mentioned in this Article

Large Language Model (LLM)

LLMs like Palmyra-Med and Palmyra-Fin are specifically trained for healthcare and finance, respectively.

Domain-Specific Model

Palmyra-Med and Palmyra-Fin are examples of domain-specific models that address unique challenges in healthcare and finance.

Inference Microservices

The partnership with NVIDIA enables Palmyra models to be accessed as inference microservices, enhancing their deployment capabilities.

Companies Mentioned in this Article

Writer

Writer's new models, Palmyra-Med and Palmyra-Fin, aim to transform healthcare and finance industries.

NVIDIA

NVIDIA's partnership with Writer enhances the performance of the Palmyra models through optimized AI software.

Get Email Alerts for AI News

By creating an email alert, you agree to AIleap's Terms of Service and Privacy Policy. You can pause or unsubscribe from email alerts at any time.

Latest Articles

Alphabet's AI drug discovery platform Isomorphic Labs raises $600M from Thrive
TechCrunch 6month

Isomorphic Labs, the AI drug discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600

AI In Education - Up-level Your Teaching With AI By Cloning Yourself
Forbes 6month

How to level up your teaching with AI. Discover how to use clones and GPTs in your classroom—personalized AI teaching is the future.

Trump's Third Term - How AI Can Help To Overthrow The US Government
Forbes 6month

Trump's Third Term? AI already knows how this can be done. A study shows how OpenAI, Grok, DeepSeek & Google outline ways to dismantle U.S. democracy.

Sam Altman Says OpenAI Will Release an 'Open Weight' AI Model This Summer
Wired 6month

Sam Altman today revealed that OpenAI will release an open weight artificial intelligence model in the coming months. "We are excited to release a powerful new open-weight language model with reasoning in the coming months," Altman wrote on X.

Popular Topics